Get started
Author

Jesús M. Fominaya

Observed names: Fominaya Gutiérrez, Jesús, Fominaya, Jesús, J Fominaya, J M Fominaya, J. Fominaya, J. Fominaya Gutiérrez, J.M. Fominaya, Jesus Fominaya, Jesus M. FOMINAYA, Jesus M. Fominaya Gutierrez, Jesús Fominaya
Observed institutions: Universidad Complutense de Madrid, Centre National de la Recherche Scientifique, Consejo Superior de Investigaciones Científicas, Inserm, University of Freiburg, Spanish National Cancer Research Centre, Centro Nacional de Biotecnología, Pitié-Salpêtrière Hospital, Centre d'Immunologie et des Maladies Infectieuses, Instituto de Biomedicina de Sevilla, Ingenasa (Spain), Université Pierre-et-Marie-Curie, Universitat de les Illes Balears, Universidad Autónoma de Madrid, Friedrich Miescher Institute
OpenAlex ID: A5111442153
Target Cell-specific DNA Transfer Mediated by a Chimeric Multidomain Protein
1996 · Jesús Fominaya, Winfried Wels · Journal of Biological Chemistry · 127
Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles
2000 · Paloma Rueda, Jesús Fominaya, et al. · Vaccine · 102
A Modular DNA Carrier Protein Based on the Structure of Diphtheria Toxin Mediates Target Cell-specific Gene Delivery
1998 · Christoph Uherek, Jesús Fominaya, et al. · Journal of Biological Chemistry · 91
PDF
Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases
2009 · Wolfgang Link, Julen Oyarzabal, et al. · Journal of Biological Chemistry · 83
Oxidation of Sulfhydryl Groups of Ribonuclease Inhibitor in Epithelial Cells Is Sufficient for Its Intracellular Degradation
1996 · Montserrat Blázquez, Jesús M. Fominaya, et al. · Journal of Biological Chemistry · 77
Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition
2010 · Carmen Blanco-Aparicio, Ana María García Collazo, et al. · Cancer Letters · 67
Cellular senescence bypass screen identifies new putative tumor suppressor genes
2007 · J F M Leal, J Fominaya, et al. · Oncogene · 64
MAP17 enhances the malignant behavior of tumor cells through ROS increase
2007 · M. V. Guijarro, J. F.M. Leal, et al. · Carcinogenesis · 62
A chimeric fusion protein containing transforming growth factor-α mediates gene transfer via binding to the EGF receptor
1998 · J Fominaya, C Uherek, et al. · Gene Therapy · 61
MAP17 overexpression is a common characteristic of carcinomas
2007 · Maria V. Guijarro, Juan F.M. Leal, et al. · Carcinogenesis · 57
Strategies to Stabilize Cell Penetrating Peptides forIn VivoApplications
2015 · Jesús Fominaya, Jerónimo Bravo, et al. · Therapeutic Delivery · 55
Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors
2012 · Joaquín Pastor, Julen Oyarzabal, et al. · Bioorganic & Medicinal Chemistry Letters · 46
Inactivation of ribonuclease inhibitor by thiol-disulfide exchange.
1992 · J.M. Fominaya, J Hofsteenge · Journal of Biological Chemistry · 44
Extreme sensitivity to Yondelis® (Trabectedin, ET‐743) in low passaged sarcoma cell lines correlates with mutated p53
2006 · Victoria Moneo, Beatriz G. Serelde, et al. · Journal of Cellular Biochemistry · 40
Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Oriented Virtual Screening Approach
2010 · Julen Oyarzabal, Natasha Zarich, et al. · Journal of Medicinal Chemistry · 38
Membrane localization of all class I PI 3‐kinase isoforms suppresses c‐Myc‐induced apoptosis in Rat1 fibroblasts via Akt
2005 · Wolfgang Link, Aranzazu Rosado, et al. · Journal of Cellular Biochemistry · 34
Imidazo[1,2-a]pyrazines as novel PI3K inhibitors
2012 · Sonia Martínez González, Ana Isabel Hernández, et al. · Bioorganic & Medicinal Chemistry Letters · 33
Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation
2011 · Irene Ferrer, Carmen Blanco-Aparicio, et al. · Cell Cycle · 31
PDF
Identification of an immunodominant epitope in the C terminus of glycoprotein 5 of porcine reproductive and respiratory syndrome virus
2001 · María Jose Rodriguez, Javier Sarraseca, et al. · Journal of General Virology · 30
Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor
2012 · Sonia Martínez González, Ana Isabel Hernández, et al. · Bioorganic & Medicinal Chemistry Letters · 27
Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate
2007 · Oliver Renner, Jesus Fominaya, et al. · Carcinogenesis · 25
Identification of PP2A/Set Binding Sites and Design of Interacting Peptides with Potential Clinical Applications
2017 · Lu Tian, Xiguang Zhang, et al. · International Journal of Peptide Research and Therapeutics · 20
Enhanced Serum Proteolysis Resistance of cell-penetrating Peptides
2015 · Jesús Fominaya, Jerónimo Bravo, et al. · Therapeutic Delivery · 20
Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR
2012 · Sonia Martínez González, Ana Isabel Hernández, et al. · Bioorganic & Medicinal Chemistry Letters · 20
Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria
2005 · Carmen Blanco-Aparicio, Belen Pequeño, et al. · Anti-Cancer Drugs · 18
Works count: 50
Citation count: 1,374
H-index: 21
I10-index: 29
Year
Topic
Type